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IKKb Leads to an Inflammatory Skin Disease
Resembling Interface Dermatitis
Angustias Page1, Manuel Navarro1, Marina Garı´n2, Paloma Pe´rez3, M. Llanos Casanova1, Rodolfo Moreno1,
Jose´ L. Jorcano1, Jose´ L. Cascallana4,5, Ana Bravo4 and Angel Ramı´rez1
IKKb is a subunit of the IkB kinase (IKK) complex required for NF-kB activation in response to pro-inflammatory
signals. NF-kB regulates the expression of many genes involved in inflammation, immunity, and apoptosis, and
also controls cell proliferation and differentiation in different tissues; however, its function in skin
physiopathology remains controversial. In this study we report the alterations caused by increased IKKb
activity in skin basal cells of transgenic mice. These animals suffered chronic inflammation with abundant
macrophages and other CD45þ infiltrating cells in the skin, which resulted in epidermal basal cell injury and
degeneration of hair follicles. They showed histological features characteristic of interface dermatitis (ID). This
phenotype is accompanied by an increased production of inflammatory cytokines by transgenic keratinocytes.
Accordingly, transcriptome studies show upregulation of genes associated with inflammatory responses. The
inflammatory phenotype observed as a consequence of IKKb overexpression is independent of T and B
lymphocytes, as it also arises in mice lacking these cell types. In summary, our data indicate the importance of
IKKb in the development of ID and in the homeostasis of stratified epithelia. Our results also support the idea
that IKKb might be a valid therapeutic target for the treatment of skin inflammatory diseases.
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INTRODUCTION
The ubiquitous NF-kB family of transcription factors regulates
the expression of many genes involved in immunity,
inflammation, and other basic cell processes such as
apoptosis and proliferation (reviewed in Hayden and Ghosh,
2008). This family is composed of dimers of five members
(NF-kB1/p50, NF-kB2/p52, RelA/p65, RelB, and c-Rel).
NF-kB is maintained inactive by binding to inhibitory
proteins of the IkB family, which results in the masking of
the nuclear localization signals of NF-kB proteins and their
cytoplasmic localization, therefore being unable to exert their
function as transcription factors. Serine phosphorylation of
IkB proteins by the IkB kinase complex (IKK) causes the
liberation and translocation to the nucleus of NF-kB. IKK is
composed of the catalytic subunits IKKa and IKKb and the
regulatory subunit IKKg/NEMO. IKKa and IKKb are highly
homologous in structure and sequence (Mercurio et al.,
1997), although they have different and non-overlapping
functions. Besides its role as a regulator of NF-kB activity,
IKKa is required in a manner independent of NF-kB for the
formation of epidermis and is also implicated in skin cancer
(Descargues et al., 2008; Moreno-Maldonado et al., 2008).
On the other hand, IKKb is required for NF-kB activation in
response to pro-inflammatory stimuli (Delhase et al., 1999),
and its absence leads to massive apoptosis of hepatocytes
dependent on tumor necrosis factor-a (TNF-a) signaling
(Tanaka et al., 1999; Li et al., 1999a, 1999b); IKKb also
regulates positively the IKK/NF-kB pathway by phosphoryla-
tion of p65 (Sakurai et al., 1999). IKKb also modulates cellular
responses in a manner independent of NF-kB; and hence, it
phosphorylates the forkhead transcription factor FOXO3a,
causing its nuclear exclusion and thus promoting cell
proliferation and breast cancer development in some patients
(Hu et al., 2004). Other proteins regulated by IKKb include
HDAC1 (Vashisht Gopal et al., 2006), Aurora kinase A (Irelan
et al., 2007), and tumor suppressors such as tuberous sclerosis
protein 1 and p53 (Lee et al., 2007; Xia et al., 2009).
Deregulation of IKKb activity is associated with different
inflammatory diseases (such as pancreatitis, diabetes, athero-
sclerosis, and inflammatory bone loss; Kanters et al., 2003;
Cai et al., 2005; Ruocco et al., 2005; Baumann et al.,
2007) and also with several types of cancer, such as
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hepatocarcinoma (Maeda et al., 2005) and colitis-associated
cancer (Greten et al., 2004; reviewed in Karin, 2006). Taken
together, these reports highlight the importance of IKKb
activity in the development of inflammatory diseases and
different types of tumors, and render this protein as an
interesting target for pharmacological inhibition in therapies
directed against these pathologies.
Although the importance of NF-kB in inflammation,
apoptosis, and the immune system is well documented, its
in vivo function in skin remains somewhat controversial.
NF-kB proteins are found in the cytoplasm of the basal cell
layer of the skin and also in the nuclei of suprabasal keratino-
cytes (Seitz et al., 1998; Perez et al., 2000), suggesting a role in
the control of the processes of proliferation and differentiation.
Several studies have shed light on the important role of NF-kB
and its regulators in skin physiopathology; genetically
modified mice with deletion of some individual NF-kB
subunits (c-Rel, p50, and p52) show no epidermal phenotype,
probably because of functional redundancy between them;
in contrast, the lack of RelB causes dermatitis (Barton et al.,
2000), and the simultaneous deletion of p65 and c-Rel in a
TNF-a-null background results in mice with thin skin, whose
keratinocytes show cell cycle progression defects (Gugasyan
et al., 2004). The lack of other components of the IKK/NF-kB
signaling pathway can also lead to skin defects. Thus, the
inactivation of one allele of the X-linked IKKg gene leads to
female mice with a skin phenotype similar to the human
genodermatosis incontinentia pigmenti (Makris et al., 2000;
Schmidt-Supprian et al., 2000) and the absence of IKKa
results in a skin unable to differentiate properly (Descargues
et al., 2008).
The connection between NF-kB activity and skin inflam-
mation is complex. The IKK/NF-kB pathway seems to
regulate the immune homeostasis of the skin, as mice with
impaired epidermal NF-kB activity by the lack of IKKg or
IKKb develop severe inflammatory skin diseases (Pasparakis
et al., 2002; Nenci et al., 2006; Stratis et al., 2006). However,
other experimental settings with increased NF-kB activity (as
in IkBa deficiency) also result in inflammatory skin pheno-
types (Klement et al., 1996; Rebholz et al., 2007). Hence,
given the clinical importance of inflammatory skin diseases,
the role of different components of the IKK/NF-kB pathway in
skin inflammation deserves additional studies. We have
analyzed the in vivo consequences of increased IKKb activity
by generating transgenic (Tg) mice with keratinocyte-specific
IKKb overexpression by using regulatory sequences from the
keratin 5 (K5) gene. Strikingly, our results show that IKKb
overactivity in this cell type causes a severe skin inflamma-
tory disease, as it occurs in animal models with keratinocyte-
restricted ablation of IKKb (Pasparakis et al., 2002; Stratis
et al., 2006).
K5-IKKb transgenic mice showed all the hallmarks of
sustained NF-kB activation, and suffered skin inflammation
with lichenoid infiltration in the upper dermis, with abundant
macrophages and lymphocytes. This inflammation was
associated with vacuolar alteration of the basilar epidermis
and the appearance of clefts at the dermoepidermal junction
in severe lesions. Together, these histological features are
characteristic of interface dermatitis (ID) (Horn and Hiatt,
2005; Sontheimer, 2009), a morphological expression of
pathological phenomena that target the dermoepidermal
junction in which the seminal event is basal cell damage;
this is usually accompanied by a diffuse, band-like (liche-
noid) infiltrate of mononuclear cells in the superficial
epidermis. A wide variety of human diseases, some of them
potentially life threatening, show the histological pattern of
ID, such as dermatomyositis, erythema multiforme, lupus
erythematosus, lichen planus, graft-versus-host reaction, and
eruptions induced by drugs. Tg IKKb mice showed deep
alterations in the profile of cytokines present in serum,
indicative of both Th1 and Th2 responses. This exacerbated
inflammatory environment seems to be triggered by the
cytokines secreted by Tg keratinocytes. Microarray analysis of
the transcriptional changes produced by IKKb overexpression
further confirmed the primarily inflammatory nature of the
phenotype found in transgenic mice. Thus, K5-IKKb mice
provide a valuable experimental model for assessing the
importance of IKKb in the development of skin diseases
showing the histological pattern of ID and could also be of
utility in the study of the implication of this protein in the
development of other diseases highly relevant from a clinical
perspective, such as skin cancer.
RESULTS
Keratinocyte-specific overexpression of IKKb leads to NF-jB
activation
K5-IKKb Tg mice were generated by pronuclear microinjec-
tion of the construct shown in Figure 1a into B6D2F2 one-cell
embryos. The 50-upstream K5-derived sequences included in
this construct drive transgene expression to the basal cells of
stratified epithelia, as well as to hair follicles and other
epithelial appendages (Ramirez et al., 1994, 2004). Immuno-
blotting analysis using specific antibodies against IKKb
(Figure 1b) and the vesicular stomatitis virus (VSV) epitope
(not shown) revealed transgenic IKKb in skin protein extracts
from several K5-IKKb Tg lines. L1 and L2 were among the
lines with higher transgenic IKKb expression and were used
for subsequent characterization. Line L1 incorporated the
transgene into an autosome whereas line L2 incorporated it
into chromosome X, resulting in male mice with higher IKKb
expression level and stronger phenotypic consequences than
females.
Immunohistochemical analysis using antibodies specific
for IKKb or for the VSV-epitope showed expression of K5-
IKKb transgene in the basal cells of the skin and in the hair
follicles, following a pattern similar to that found for keratin
K5 (Figure 1c). It was also detected in basal cells of other
stratified epithelia (such as palate and forestomach, not
shown).
To determine the biochemical consequences of IKKb
overexpression, we studied the extent of IKK/NF-kB pathway
activation. In Tg skin, increased phosphorylation of both p65
and IkBa (direct targets of IKKb-mediated phosphorylation)
were found (Figure 1b). By measuring the phosphorylation of
recombinant IkBa in the presence of [g-32P]ATP in an in vitro
kinase assay, higher IKK activity in extracts from Tg was
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detected than from wild-type (WT) skin (Figure 1d). Together,
these results indicate that Tg IKKb is expressed, it is
functional, and it increases the activity of IKK complexes.
We also analyzed NF-kB binding activity in skin protein
extracts of K5-IKKb Tg mice using a labeled oligonucleotide
containing consensus kB binding sites. An increase in NF-kB
binding was observed in both transgenic lines (Figure 1e, left
panel) and essentially the same results were obtained when
we measured the NF-kB binding activity in ELISA assays
(Figure 1f). It is interesting to note that the nature of the NF-kB
complexes did not change in Tg skin, as p50/p65 and p50/
p50 dimers were detected in supershift assays in protein
extracts from both WT and Tg skin (Figure 1e, right panel).
To analyze the effects of IKKb overexpression in epidermal
keratinocytes while avoiding the interference of other cell
types present in skin, we studied in vitro cultures of
keratinocytes from newborn L1 Tg and WT littermates (L2
keratinocytes were not used because of the anticipated
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Figure 1. IjB kinase (IKK) and NF-jB activities are increased in K5-IKKb transgenic (Tg) mice. (a) Diagrammatic representation of the transgene. (b) Western
blot analysis of total protein extracts from the back skin of 8-week-old male wild-type (WT) and Tg mice. The membranes were sequentially probed with
antibodies for the indicated proteins. b-Actin was used as a loading control. (c) Immunohistochemical analysis of K5-IKKb transgene expression in back skin of
9-month-old L1 mice. Antibodies against both vesicular stomatitis virus (VSV)-tag and IKKb gave positive signals in hair follicles (arrowhead) and basal
epidermal cells (arrows), in a similar pattern to that obtained for K5; in these staining conditions, endogenous IKKb is not detected. (d) In vitro kinase assay.
Western blots for IKKb and IKKa are also shown. Protein extracts proceed from female mice. (e) Electrophoretic mobility shift assay (EMSA) analysis of the
DNA-binding activity of total protein extracts from the back skin of male mice of the indicated genotypes using a radiolabeled NF-kB oligonucleotide (left
panel). WT and L2 protein extracts were subjected to a supershift assay using antibodies against p65 or p50, as indicated (right panel). The components present
in each band, as judged by the supershifts obtained, are indicated on the left margin. Numbers below the left panel indicate the mean intensity of the p50/p50
and p50/p65 bands in relation to the WT sample. (f) NF-kB activity estimated by ELISA analysis of p50 binding to NF-kB consensus sequences using back skin
extracts of 32-day-old mice. Scale bar¼ 100mm in the photographs of panel c. (*Po0.05, Mann–Whitney (Wilcoxon) W-test.)
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differences between male and female animals). When we
analyzed fibroblasts and keratinocytes separately, both
increased phosphorylation of IKKb targets (p65 and IkBa)
and decreased steady-state level of IkBa affected mainly
to transgenic keratinocytes, which is the cell type with
increased IKKb expression (Figure 2a). Other components of
IKK complex (IKKa and IKKg) were not affected by IKKb
overexpression. We then treated Tg and WT keratinocytes
with TNF-a, which is a stimulating agent of IKK/NK-kB
pathway, for different lengths of time. At 5minutes of
treatment, both genotypes showed a clear increase in P-p65
and P-IkBa and a slight decrease in IkBa when compared
with the signal obtained in untreated keratinocytes (namely
t¼ 0, Figure 2b). Although showing signs of activated NF-kB
signaling (i.e., increased P-IkBa and P-p65 and decreased
level of IkBa at t¼ 0), Tg keratinocytes retain to some extent
the ability of further activating this pathway upon stimulatory
conditions, such as TNF-a treatment.
We studied the consequences of IKKb overexpression in
keratinocytes by analyzing cell survival after the treatment of
keratinocyte cultures with TNF-a and cycloheximide. In
agreement with the increased basal activity of this survival
pathway in Tg keratinocytes, these cells became more
resistant to apoptosis than WT keratinocytes (representative
fields are shown in Figure 2c), resulting in an almost 2-fold
increase in the percentage of cell survival (Figure 2d).
Proliferation, in contrast, was not affected, as no differences
were observed in the percentage of BrdU-incorporating cells
or in the growth curves between Tg and WT keratinocytes
(not shown). Hence, IKK/NK-kB pathway overactivity has
physiological consequences in Tg keratinocytes, protecting
cells against apoptosis induced by TNF-a.
K5-IKKb Tg mice present ectodermal alterations and
inflammation of skin
K5-IKKb transgene expression led to the appearance of
several macroscopic alterations in ectodermal derivatives in
both lines, although with different penetrance. The majority
of newborn males of L2 line showed opened eyes (not
shown), approximately 50% of the transgenic mice from both
lines showed alterations in exocrine glands or teeth, and all
L2 transgenic mice (males more pronouncedly than females)
and approximately 10% of the L1 mice showed a skin
phenotype that finally led to lichenification (characterized by
thickened, hyperpigmented, and hairless skin). These animals
showed signs of pruritus, erythema (Figure 3a), ulcers, and
progressive alopecia (Figure 3b); these phenotypic alterations
were first detected in young animals, before the first month of
life. Histological analyses confirmed these observations and
showed that overexpression of IKKb leads to significant
alterations of the skin and ectodermal derivatives. The
lichenification and hyperpigmentation of the skin of aged
mice appeared microscopically as extensive areas with
severe epidermal hyperplasia plus the transformation of hair
follicles into structures lacking their usual layered arrange-
ment and unable to form hair (Figure 3c; compare with WT
back skin in Figure 3f). These animals also showed pigment
incontinence and melanophages in the dermal papillae
(Figure 3c). A variable degree of basal epidermal clefting
was also observed depending on the severity of the skin
phenotype, along with occasional clusters of necrotic
keratinocytes (arrowheads and arrow, respectively, in the
insert of Figure 3c). This skin phenotype began with small
areas of lichenoid infiltration of mononuclear, inflammatory
cells at the papillary dermis, associated with vacuolar
alteration and necrosis of the basal keratinocytes and
migration of leucocytes into the epidermis; all these findings
are characteristic of ID and were also visible in the epidermis
of the foot sole, ears (Figure 3d, arrows), and tail (not shown).
Transmission electronic microscopy studies further confirmed
the severe vacuolar alteration of the cytoplasm and the nuclei
of keratinocytes (Figure 3e). It is noteworthy that the
lichenoid infiltration observed in Tg skin seems to be very
similar to that observed in cell-poor ID. These results
highlight the possible role of IKKb and NF-kB overactivity
in the origin of ID.
K5-IKKb Tg mice with unaltered back skin showed the
normal expression pattern of differentiation markers (K5, K6,
K10, loricrin, filaggrin, and involucrin; not shown), indicating
that overactivity of IKK/NF-kB pathway in these animals does
not affect the normal differentiation of epidermis. In contrast,
Tg mice with the pathological events of ID showed increased
expression of K5, K10 (markers of basal and suprabasal
layers, respectively), and K6 (a marker of the inner root sheath
of the hair follicles and hyperproliferative epidermal cells),
consistent with the epidermal hyperplasia observed in the
severe skin phenotype (Figure 3c and f). No substantial
differences were detected in terms of the expression of
terminal differentiation markers (loricrin and filaggrin; not
shown).
Altogether, these results indicate that the increase of IKKb
expression and NF-kB signaling in the skin of K5-IKKb Tg
mice leads to the progressive appearance of a severe skin
phenotype of ID that ends in lichenification.
Typification of the inflammation in skin of K5-IKKb transgenic
mice
IKKb is an important mediator of inflammation because
of its regulation of NF-kB activity. To analyze the nature of
the spontaneous lichenoid infiltration observed in the
skin of K5-IKKb Tg mice, we performed an immunohisto-
chemical examination of the infiltrating cells in males of L2
line. No differences were observed between Tg and WT
mice in the skin at postnatal day 2 (P2) or P7 (Figure 4a
and results not shown). From P13 onwards, infiltrating
CD45þ cells were predominant in Tg skin (Figure 4b–e).
Immunostaining with an antibody specific for macrophages
also showed an increase in this cellular type at P16, which
lasted subsequently (Figure 4c–e). This infiltrate was observed
in young Tg mice well before the appearance of any skin
phenotype (Figure 4c), suggesting that the increased
density of CD45þ cells is related to the increased activity
of IKKb in epidermal cells and not to basal cell damage. Adult
Tg skin also showed abundant CD3þ cells (T lymphocytes) in
both the dermal and epidermal compartments of the skin
(Figure 4e).
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IKKb activation leads to changes in the expression profile of
genes related to inflammation and immune response of skin
To understand the global effects of increased IKKb expres-
sion, we performed a genome-wide analysis of gene
expression patterns comparing male WT and L2 Tg mice
skins at the age of 32 days, before the severe phenotype
shown in Figure 3 is established. At this time there is no
evidence of skin damage but the hair follicles have not
proceeded to second anagen in the transgenic mice (Figure
4d). Microarray data analysis resulted in 1,291 upregulated
and 764 downregulated genes in the skin of K5-IKKb mice.
Among the upregulated genes, we found a near 5-fold
induction in IKKb expression and also upregulation of other
genes of the IKK/NFkB signaling pathway (full results are
provided in Supplementary Table S1 of Supplementary
materials online).
The majority of the induced genes were related to the
development of the immune response (Supplementary Table
S2 online). In particular, the IFN-g response seems to be
highly activated. IFN-g regulates several families of genes
involved in immune response, many of which are strongly
induced, indicating that a well-orchestrated response to the
inflamed tissue has been triggered. Many cytokines, chemo-
kines, and their receptors, as well as TNF-a-regulated genes
were also induced. Although some of these upregulated
genes may originate from immune cells in the skin,
keratinocytes actually overexpress at least some of these
factors (see below).
On the contrary, the repressed genes are mostly skin
related. Although some keratin genes were upregulated,
almost all hair keratins and keratin-associated proteins, the
principal constituents of hair, as well as transcription factors
involved in epidermal development, were strongly repressed
(Supplementary Table S3 online). This is in agreement with
the lack of progression to anagen observed in transgenic
follicles at this age.
In summary, microarray analysis suggests that IKKb
overexpression in basal keratinocytes results in two different
main effects: downregulation of the hair follicle development
and induction of immune response in the skin.
Skin phenotype is independent of T and B cells
It is known that medullary thymic epithelial cells express K5
from embryonic day 13.5 onwards (Ramirez et al., 1994) and
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Figure 2. Changes associated with IKKb overexpression in keratinocytes. (a) The K5-IKKb transgene is functional in keratinocytes. Keratinocytes (K) and
fibroblasts (F) from L1 and wild-type (WT) mice were separated and cultured in vitro, and protein extracts were blotted against the indicated antibodies.
(b) WT and transgenic (Tg) keratinocytes respond to tumor necrosis factor-a (TNF-a) treatment with a transient increase in P-p65 and P-IkBa, and a reduction
in IkBa, although the baseline (t¼ 0) concentrations of these proteins differ greatly between the Tg and WT mice. (c–d) IKKb overexpression protects
keratinocytes against apoptosis when treated with TNF-a and cycloheximide (CHX). Representative images of cultured cells are shown in (c), and the
percentage of surviving cells in (d). Scale bar¼ 500mm. (*Po0.05, Mann–Whitney (Wilcoxon) W-test.)
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transgenes controlled by the K5 regulatory sequences used in
this study have shown epithelial thymic expression (Robles
et al., 1996). Hence, the inflammatory phenotype observed in
K5-IKKb transgenic mice could be due, at least partly, to an
altered development or function of the immune system in K5-
IKKb Tg mice. We analyzed the expression of IKKb in thymus
of Tg and WT mice; epithelial cells from thymic medulla
express IKKb in Tg mice (not shown). These results
substantiate the possibility that thymus alterations could
underlie the inflammatory phenotype of Tg mice. We
performed a FACS analysis to study the distribution of CD4-
or CD8-positive T cells in spleen and thymus, and found no
changes in the percentage of single- or double-positive cells
in both lines of Tg mice with respect to WT mice; we did not
Foot sole
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Tg Tg
D
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D
E
D
E
D
Ear K5 K6
Figure 3. Skin phenotype in transgenic (Tg) mice. (a,b) Phenotypic manifestations in Tg mice are shown: erythema in young mice (a) and hair loss and skin
lichenification in older mice from L2 line (b). (c) Severe skin phenotype in aged L2 Tg mice. Extended areas of the epidermis are bald, hyperplastic, and show
altered hair follicles and severe pigment incontinence (arrows). Insert: higher magnification, showing necrotic basal keratinocytes (arrow) and a region with
epidermal clefting by severe vacuolar degeneration of keratinocytes in the basal layer (arrowheads). (d) Lichenoid infiltration associated with vacuolar alteration
of the basal epidermal cells in skin from other locations. Note in the Tg tissues the presence of inflammatory cells affecting the basal cell layer and the upper
dermis (arrows). The epidermis (E) and dermis (D) are indicated. (e) Ultrastructure of epidermal keratinocytes showing severe vacuolar degeneration of the
cytoplasm and nucleus. (f) Increased expression of differentiation markers in altered Tg skin of L2 males. K5 is expressed in all the layers of the epidermis and
hair follicles; K6 expression is limited to hyperplastic epidermal layers. Scale bar¼ 500mm in panel c, ¼ 50 mm in inset of panel c, ¼ 5 mm in panel e,
and ¼ 100mm in panels d and f.
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Figure 4. Skin inflammation in K5-IKKb transgenic (Tg) mice. (a–e) Back skin sections of wild-type (WT) and L2 Tg males were stained with antibodies
specific for CD45, F4/80, and CD3 (characteristic of infiltrating cells, macrophages, and T lymphocytes, respectively) at different ages (a: P2; b: P13; c: P16;
d: P32; e: 4 months for CD45 and F4/80 and 2 months for CD3). Note the increased infiltration of macrophages and other inflammatory cells in the
skin of Tg mice from 13 days onwards. Scale bar¼200 mm in panels a–c and ¼100 mm in panels d and e.
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find either any skewing of T-cell repertoire evidenced by Vb-
TCR analysis in thymus (not shown). We therefore conclude
that the expression of IKKb in thymus of Tg mice does not
alter the development or functionality of T lymphocytes, and
that K5-IKKb Tg mice seem to have a fully competent
immune system.
To unravel the putative dependence of the inflammatory
phenotype of K5-IKKb Tg mice on a functional immune
system, we performed a series of skin transplants from young
L2 male mice (2 or 12 days old) to immunodeficient NOD-
SCID (nonobese diabetic/severe combined immunodeficient)
mice that lack both T and B cells (Prochazka et al., 1992).
Skin grafts were removed and studied at 10, 15, and 17 weeks
after transplantation, obtaining essentially the same results.
Macroscopically, grafted L2 skin was hairless at the end of the
experiment, as observed in aged L2 male mice (compare
Figures 3b, and 5a and b). Microscopically, host and
transplanted skin can be identified by the presence of
pigmentation and the absence of telogenic hair follicles in
the transplanted skin; in addition, L2 transplanted skins show
increased dermal cellularity and the presence of altered hair
follicles, morphologically similar to those found in non-
transplanted L2 male skin (compare Figure 3c with Figure 5c,
e, g, and i). It is important to note that L2 skin grafts retain K5-
IKKb expression over the transplantation period (Figure 5e).
We found more infiltrating CD45þ cells and more macro-
phages in transplanted than in host skin, especially in L2 Tg
skin in which F4/80þ cells were as abundant as in non-
transplanted L2 male skin (compare Figures 4e and 5i). In
brief, we found the same cell autonomous skin phenotype,
with abundant inflammatory cells and altered hair follicles, in
grafted Tg L2 skin as in immunocompetent Tg mice (Figures
4e and 5). This result indicates that the alterations found in
skin as a consequence of IKKb overactivity are independent
of the presence of functional T and B cells.
Altered cytokine balance in K5-IKKb transgenic mice
Growing evidence has shown that inflammatory mediators
(cytokines and chemokines) released from keratinocytes
could trigger innate inflammatory immunity in the skin. As
the production of many cytokines and chemokines is
regulated by NF-kB, we reasoned that the NF-kB overactivity
found in K5-IKKb skin could lead to an increased production
of these inflammatory mediators, and finally to the inflam-
matory phenotype found in K5-IKKb Tg mice. To test this
hypothesis, we used a multiplex assay and ELISA to monitor
the level of several cytokines in the serum of WT and Tg
males of L1 and L2 lines. As shown in Figure 6a, we found
important changes in the concentration of Th1 (IL-2 and
IFN-g) and Th2 (IL-4, IL-5, IL-6, and IL-10) cytokines in
L2 Tg animals. Among the altered cytokines, some are pro-
inflammatory (IL-1a, IL-6, and TNF-a) and others have anti-
inflammatory activity (IL-4 and IL-10). L1 Tg animals showed
changes in only a subset of these cytokines (i.e., IL-2, IL-6,
and IL-10). We have also detected statistically significant
increases in L2 line in the concentration of GM-CSF (a
pleiotropic molecule important for macrophage function and
differentiation) and CCL2 (a chemoattractant protein for
macrophages). Altogether, these data reveal the complexity
of the inflammatory response found in K5-IKKb L2 Tg mice,
with large changes found in several different cytokines; some
of these changes, instead of being a direct consequence of the
increased level of IKKb in epithelial keratinocytes, could
reflect a secondary reaction to the initial changes due to
keratinocyte NF-kB overactivity.
To determine what primary alterations are caused by IKKb
in cytokine synthesis in keratinocytes, we analyzed the
production of several cytokines that are known transcrip-
tional targets of NF-kB by measuring their concentration in
the supernatants of cultures of epidermal keratinocytes. We
observed a significant increase (between 3 and 10 times) in
the concentration of IL-1a, IL-6, TNF-a, GM-CSF, and CCL2
in the cultures of Tg keratinocytes (Figure 6b). Although both
L1 and L2 keratinocytes secrete similar amounts of cytokines,
the serum concentration of several cytokines (IL-1a, IL-4,
Host skin
Transplanted skin
Host skinTransplanted skin
Tg transplanted skin WT transplanted skin
a b
c d
e f
g h
i j
Figure 5. The phenotype of skin is independent of T and B cells. Gross
(a, b) and microscopic appearance (c, d) of skin transplanted onto NOD/SCID
mice at 15 weeks after transplantation. IKKb immunohistochemistry (e, f)
and the presence of positive cells for CD45 (g, h) and F4/80 (i, j) antigens
are shown. (a, c, e, g, i) K5-IKKb transgenic (Tg) L2 male transplants.
(b, d, f, h, j) Transplants from a wild-type (WT) littermate. In c and d, arrows
indicate hair follicles from transplanted skin (pigmented and anagenic) and
arrowheads indicate unpigmented and telogenic follicles from receptor
origin. In i–j, arrows indicate some positive cells for the indicated staining;
arrowheads indicate pigmented hair follicles. Scale bar¼500 mm in panels c
and d and ¼ 200 mm in panels e–j.
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IL-5, IFN-g, TNFa, GM-CSF, and CCL2; Figure 6a) and the
phenotypic consequences, in terms of skin inflammation, are
markedly different in L1 and L2 mice. These apparently
contradictory results could reflect the fact that the expression
level of the transgene in interfollicular keratinocytes (the cells
contributing to the keratinocyte cultures) is similar in both
lines; in contrast, L2 follicular keratinocytes express at higher
level (not shown), thus resulting in deeper alterations in the
concentration of serum cytokines and hence in more severe
phenotypic consequences.
The milieu of NF-kB-regulated pro-inflammatory and
chemotactic molecules oversecreted by transgenic keratino-
cytes could represent the primary call to inflammatory cells
in vivo; the observed changes in serum concentration of other
cytokines suggest the participation of cells from the immune
system in response to the altered cytokine profile secreted by
keratinocytes in Tg mice.
DISCUSSION
In this report, we describe the consequences produced by
IKKb overactivity in K5-IKKb Tg mouse skin. The skin and the
keratinocytes of these animals fulfill the criteria to conclude
that IKKb/NF-kB signaling pathway is activated. The main
alteration found in K5-IKKb Tg mice is the appearance of a
skin inflammatory disease with a lichenoid infiltrate com-
posed of several infiltrating cell types that shows histological
features characteristic of ID.
It is widely accepted that the IKK/NF-kB pathway is
implicated in promotion of cell survival and carcinogenesis.
However, in some cases the functions of the different proteins
implicated in this signaling pathway may vary depending on
the cell type and the experimental conditions under study,
possibly because of unknown differences in the complex
network of signaling pathways operating in each condition.
Therefore, it is advisable to study the function of the different
proteins involved in this pathway using different models. In
skin, some of the accepted roles of NF-kB contrast with those
accepted for other cell types, and some controversies exist.
Thus, animal models with skin-specific NF-kB inhibition by
expression of a super repressor form of IkBa show skin
hyperplasia and even carcinoma occurrence (Seitz et al.,
1998; van Hogerlinden et al., 1999), although growth
deficiencies in keratinocytes with impaired NF-kB activity
by deletion of IKKb have also been reported (Pasparakis et al.,
2002). In this study, we have not found alterations in the
proliferation of cultured keratinocytes from K5-IKKb Tg
animals, suggesting that the proliferative functions exerted
by IKKb and NF-kB in keratinocytes are fulfilled by the
normal activity level of NF-kB and that an increase in this
level does not affect keratinocyte proliferation. In contrast,
histological analyses of K5-IKKb Tg mice showed hyperplasia
of the skin (see Figure 3), probably due to the continuous
insult of basal cell keratinocytes by inflammatory cells that
are not present in vitro.
Although the tumor promoting activity of IKKb has been
manifested in different tissues and cell types (Greten et al.,
2004; Hu et al., 2004; Maeda et al., 2005), the lack of
spontaneous transformation of K5-IKKb skin keratinocytes is
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Figure 6. Cytokine and chemokine levels in the serum and in cultured keratinocytes from transgenic mice. (a) Levels of cytokines and chemokines in the serum
of 32-day-old transgenic (Tg) and wild-type (WT) male mice. For IL-1a, IL-5, and CCL-2, the actual values have been multiplied by 10 (indicated by  10),
to see more clearly the differences between WT and Tg samples (i.e., the actual average value for IL-1a WT samples is 40 pgml–1). (b) Concentration of
cytokines and chemokines accumulated in the supernatants after 48 hours of culture of the same number of keratinocytes from WT, L1, or L2 mice.
The values for GM-CSF and CCL-2 have been divided by 10 and 100, respectively (*Po0.05, Mann–Whitney (Wilcoxon) W-test).
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noteworthy. In this particular cell type, IKKb does not induce
tumor development, at least during the murine lifespan.
Animal models with skin-specific IKKb inactivation have not
been useful for the determination of the role exerted by
IKKb onto epidermal carcinogenesis because of their
limited viability (Pasparakis et al., 2002; Stratis et al.,
2006). The animal model described in this report could be
useful in deciphering the possible role of IKKb in epidermal
carcinogenesis.
IKKb is considered to have a key role in inflammatory
processes, as it is needed for NF-kB activation in response to
pro-inflammatory stimuli. However, some published data
indicate an inhibitory role of IKKb and NF-kB in skin
inflammation. Thus, both skin from rela–/– c-rel–/– embryos
transplanted onto immunodeficient mice (Gugasyan et al.,
2004) and skin-specific deletion of IKKb or IKKg leads to
inflammatory skin diseases. Our results indicate that the role
of IKKb in regulating skin inflammation is multifaceted, as
increased expression of this IKK catalytic subunit may also
induce a skin inflammatory phenotype. Probably, the
inflammatory diseases developed in animal models with
either increased or diminished NF-kB activity in the skin are
the result of different processes; the deletion of IKKb (or other
NF-kB regulators, such as IKKg) in the skin results in the
development of an inflammatory phenotype in response to
increased apoptosis driven by TNF-a (Pasparakis et al., 2002;
Nenci et al., 2006; Stratis et al., 2006). In K5-IKKb Tg mice,
the inflammatory response is characterized by the dermoe-
pidermal infiltration of macrophages and other inflammatory
cell types before we can detect other phenotypic mani-
festations in the skin, thus indicating that basal cell damage
and subsequent phenotypes are secondary to the action
of inflammatory cells. Keratinocytes overexpressing IKKb
secrete higher amounts of pro-inflammatory cytokines and
chemotactic molecules that are known transcriptional targets
of NF-kB (Figure 6b); these molecules may attract and
activate macrophages and other inflammatory cells already
present at the age of P13. Thus, basal cell damage and the
complex inflammatory disease developed by K5-IKKb Tg
mice are probably caused by infiltration of inflammatory
cells, as described in hypersensitivity reactions of the skin to
drugs in association with vacuolar ID (Pichler et al., 2002). It
is interesting to emphasize the cell autonomous nature of the
phenotype found, as showed by the transplants of Tg skin
onto immunodeficient mice, in which the inflammatory
infiltrate and the subsequent phenotypes affect only the
transplanted Tg skin and not the receptor skin. Our
microarray analysis further confirms the primary inflamma-
tory nature of the phenotype found in K5-IKKb Tg mice. In
addition, as many downregulated genes are involved in hair
follicle development, our results suggest a dual effect of IKKb
in skin physiopathology. On one hand, it induces immune
responses, and on the other, it inhibits the terminal
differentiation of keratinocytes toward hair follicle. As a
consequence, there is an immune response against the
altered epidermal cells, which ultimately causes skin lesions.
Skin inflammatory diseases are complex entities, clinically
of great importance, whose pathogenesis involve the
interaction of different cell types. In many cases, the
mechanisms underlying these diseases are still an enigma.
In some instances (i.e., psoriasis), it seems that T cells and
keratinocytes can trigger the signals that lead to the disease,
although other cell types, such as dendritic cells (Zaba et al.,
2009) and macrophages (Stratis et al., 2006) also have
pathogenic importance.
In the case of diseases with the clinical manifesta-
tions of ID, both interferon signaling and the autoimmune
response of the epidermis by T cells have been considered
central events in their pathogenesis (Meller et al., 2009;
Sontheimer, 2009). Our results indicate that an inflamma-
tory disease with a lichenoid tissue reaction in skin can
be originated as a consequence of an altered expression
of IKKb in the keratinocytes. Furthermore, the skin trans-
plantation experiments indicate that T and B cells are not
mandatory for the occurrence of these diseases, as the ID
phenotype characteristic of K5-IKKb Tg skin is also developed
when unaffected neonatal Tg skin are transplanted onto
immunodeficient mice, lacking both T and B lymphocytes.
Further experiments will be needed to determine what
inflammatory cellular types are responsible of the phenotype.
K5-IKKb Tg mice eventually develop epidermal hyperpla-
sia, scarring alopecia, and hyperpigmentation. All these
features are common sequelae in patients suffering from ID
as a consequence of inflammatory processes affecting the
dermal–epidermal interface (such as eruptions produced by
drugs, lichen planus, benign lichenoid keratosis, and
erythema multiforme) (Spielvogel and Kantor, 2005). Thus,
K5-IKKb Tg mice represent a valuable animal model for
analyzing the physiopathology of ID and the relationship
between chronic inflammation and epithelial damage.
In summary, this study indicates a central role for IKKb in
epithelial homeostasis, in regulating skin inflammation and
immunity, and in the pathogenesis of diseases that course
with ID. IKKb emerges as a key molecule responsible for skin
inflammatory diseases, and hence as a potential therapeutic
target for the treatment of these pathologies.
MATERIALS AND METHODS
Mice and treatment
VSV-tagged human IKKb was placed under the control of a 5.2 kb 50-
upstream fragment of bovine K5 and a rabbit b-globin intron (Figure
1a). Tg mice were generated by microinjection of the latter construct
into B6D2F2 embryos using standard techniques (Hogan et al, 1994)
and Tg lines were maintained by crossing with B6D2F1 mice. Mice
were genotyped by PCR analysis of tail genomic DNA using primers
specific for the rabbit b-globin intron. Non-Tg littermates were used
as control animals. All experimental procedures were performed
according to the European and Spanish laws and regulations and
approved by our institution’s ethics committee.
Cell culture and treatments
For primary mouse keratinocyte cultures, the skin epidermis of P2
or P3 Tg and WT littermates was separated from the dermis by
trypsinization with 0.25% trypsin (ICN Biomedicals, Irvine, CA) in
phosphate-buffered saline. Primary keratinocytes were seeded at a
density of 1 106 cells per 35-mm-diameter Petri dish (or equivalent
www.jidonline.org 1607
A Page et al.
IKKb Causes Skin Inflammation
concentrations) in Ca2þ -free and Mg2þ -free Eagle’s minimal essential
medium (BioWhittaker, Walkersville, MD; Cambrex, Charles City, IA)
supplemented with 4% Chelex-treated (Bio-Rad, Hercules, CA) fetal
bovine serum (Cultek, Madrid, Spain) and 0.2mM Ca2þ . After 24hours,
the medium was replaced by fresh medium containing 0.05mM
Ca2þ and 10 ngml–1 epidermal growth factor (Sigma, St Louis, MO).
Subconfluent keratinocytes were treated with 20ngml–1 TNF-a (Sigma)
for the indicated times (Figure 2). The dishes were then washed twice
with cold phosphate-buffered saline and cells were then scraped off,
pelleted, and the protein extracts subjected to western blotting.
Determination of apoptosis
Apoptosis assays were performed as described in Brummelkamp
et al. (2003). In brief, subconfluent 60mm dishes were treated for
16 hours with 10 ngml–1 TNF-a (Sigma) and 10mgml–1 cyclohex-
imide (Sigma). The percentages of viable cells were quantified by
Trypan blue exclusion. The means obtained from six different
experiments (two plates for each experimental condition) are
presented.
Western blotting, electrophoretic mobility shift assay, ELISA,
and in vitro kinase assays
Nuclear, cytoplasmic, and whole-cell protein extracts from mouse
skins and primary keratinocytes were prepared as described in Perez
et al. (2001). The antibodies used in western blotting were those
against IKKa, IkBa, p50, p65, actin, RelB (Santa Cruz Biotechnology,
Santa Cruz, CA), P-p65 (Ser536), P-IkBa (Ser32) (Cell Signaling,
Danvers, MA), IKKb (Imgenex, San Diego, CA), VSV tag (MBL,
Nagoya, Japan), and tubulin (Sigma). For electrophoretic mobility
shift assay, whole-cell extracts were incubated with a kB oligo-
nucleotide (coding strand: 50-GATCCAACGGCAGGGGAATTCCCC
TCTCCTTA-30). The composition of the retarded complexes was
determined by supershift experiments using antibodies specific for
p50 and p65. Complexes were separated on 5.5% polyacrylamide
gels, dried, and analyzed. Specific bands were quantified using
a phosphor imager, giving a value of 1 to kB binding in WT skin.
ELISA assays (NF-kB p50/p65 transcription factor assay colorimetric,
Chemicon International, Temecula, CA) were performed according
to the indications of the manufacturer. In vitro kinase assays were
performed essentially as described in Tanaka et al. (1999). IKK
complexes from back skin extracts were immunoprecipitated with
a mixture of antibodies against IKKa, IKKb, and IKKg, incubated
with sepharose A/G beads, and washed. Immunoprecipitates were
incubated with the substrate IkBa (all reagents from Santa Cruz
Biotechnology) in the presence of [g-32P]ATP, and the amount of
phosphorylated IkBa quantified using a Molecular Imager (Bio-Rad).
Histology and immunohistochemistry
Mouse tissues were dissected and immediately frozen in optimal
cutting temperature compound or fixed in formaldehyde or 70%
ethanol and embedded in paraffin. Sections, 5 mm thick, were
used for hematoxylin and eosin staining or immunohistochemical
preparations. Tissue cryosections were fixed for 10minutes at
20 1C in acetone. The antibodies used were those against IKKb
(Imgenex), K5, K6, and K10 (Covance, Princeton, NJ), F4/80
(CALTAG laboratories, Bangkok, Thailand), B220, Gr-1, and CD45
(Pharmingen, San Diego, CA; BD Biosciences, San Jose, CA), VSV-G
Tag (MBL), and CD3 (DakoCytomation, Glostrup, Denmark).
Immunoreactivity was revealed using an ABC avidin-biotin-peroxidase
system and ABC substrate (Vector Laboratories, Peterborough, UK), and
the sections counterstained with hematoxylin.
Transmission electron microscopy
Skin samples from adult Tg and WT mice were fixed in 2.5%
glutaraldehyde in 0.1M phosphate-buffered saline (pH 7.5), and
postfixed in 1% osmium tetroxide before dehydration and embed-
ding in Epon 812 resin (Shell Chemical Co, San Francisco, CA).
Ultrathin sections were stained with uranyl acetate and lead citrate.
Microarray hybridization and analysis
For extraction of RNA for microarrays, shaved back skin samples
were frozen in liquid nitrogen immediately upon dissection. Frozen
samples were disaggregated in Trizol using a Polytron homogenizer.
RNA was purified using RNAeasy columns (Qiagen, Hilden, Germany),
and its quality was checked using an Agilent Bioanalyzer 2100 (Santa
Clara, CA). Two different arrays were analyzed for each condition
and each individual microarray sample consisted of RNAs pooled
from three different animals. Samples were labeled, hybridized, and
processed according to the established Affymetrix protocol (Santa
Clara, CA), using the mouse genome 430 2.0 chip. Array data have
been submitted to the Gene Expression Omnibus (accession number
GSE17511). Data processing and identification of differentially
expressed genes was carried out in the R environment for statistical
computing and programming (http://www.R-project.org) using the
Bioconductor package bundle (Gentleman et al., 2004). The original
CEL files were normalized with Robust Multichip Average method,
and differentially expressed genes were identified using the empirical
Bayes moderated t-test implemented in the Limma package (Smyth,
2004). Annotations were based on data provided by EntrezGene (Build
37.1, National Center for Biotechnology Information, Bethesda, MD).
Probes that showed a 42-fold change, an adjusted P–value of o0.01,
and had a ‘‘present call’’ in all controls (for downregulated genes) or
target arrays (for upregulated genes) were selected for further study.
Functional annotation and analysis based on the Gene Ontology
classification were performed with the DAVID (Database for Annota-
tion, Visualization and Integrated Discovery) tool (Dennis et al., 2003).
Only EASE scores of o0.01 were considered as overrepresented.
Finally, results were manually curated.
Skin transplants
Skin samples around 3 cm2 from L2 and WT mice were transplanted
and sutured onto the back of 9-week-old female NOD-SCID mice
following sterile surgical procedures.
Cytokine analysis
For the detection of cytokines in serum and culture media, a
multiplex detection system was used (Flow Cytomix mouse Th1/Th2
10-plex, BMS820FF; Bender MedSystems GMBH, Vienna, Austria)
following the indications of the manufacturer.
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